Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urinary Bladder Neoplasms × trametinib × Clear all

Sponsor

Conditions

Melanoma 28 Neoplasms 15 Carcinoma, Non-Small-Cell Lung 7 Multiple Myeloma 5 Hematologic Neoplasms 5 Neoplasm Metastasis 4 Lymphoma 3 Leukemia, Myeloid, Acute 3 Colorectal Neoplasms 3 Brain Neoplasms 3 Biliary Tract Neoplasms 3 Thyroid Neoplasms 2 Thyroid Cancer, Papillary 2 Skin Neoplasms 2 Glioma 2 Cholangiocarcinoma 2 Bile Duct Neoplasms 2 Adenocarcinoma, Follicular 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Oligodendroglioma 1 Nonseminomatous germ cell tumor 1 Neurofibromatosis 1 1 Neurofibroma, Plexiform 1 Neurocytoma 1 Neuroblastoma 1 Myelodysplastic Syndromes 1

Interventions

Gemcitabine 47 Cisplatin 32 pembrolizumab 28 Paclitaxel 13 Docetaxel 13 avelumab 12 Mitomycin 12 atezolizumab 11 Nivolumab 11 Cystectomy 9 Carboplatin 9 durvalumab 7 Sunitinib 7 apaziquone 6 Doxorubicin 6 BCG Vaccine 6 5-aminolevulinic acid hexyl ester 6 Vinblastine 5 Platinum 5 Methotrexate 5 Magnetic Resonance Spectroscopy 5 Albumin-Bound Paclitaxel 5 Taxes 4 Standard of Care 4 Sorafenib 4 Radiotherapy 4 Radiation 4 Fluorouracil 4 Erlotinib Hydrochloride 4 1,2-diaminocyclohexaneplatinum II citrate 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡